Indian firms question reliability of US IP fears

Save

As the US-India slugfest over intellectual property rights (IPR) issues intensifies, Indian pharmaceutical firms have ramped up their rebuttal of the evidence behind US arguments. They point out that international bodies have explicitly clarified that…